Beyond ketosis: the search for the mechanism underlying SGLT2-inhibitor benefit continues.

J Clin Invest

Division of Nutritional Science and Obesity Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

Published: December 2024

Despite the impressive clinical benefits and widespread adoption of sodium glucose cotransporter 2 inhibitors (SGLT2i) to treat all classes of heart failure, their cardiovascular mechanisms of action are poorly understood. Proposed mechanisms range broadly and include enhanced ketogenesis, where the mild ketosis associated with SGLT2i use is presumed to be beneficial. However, in this issue of the JCI, carefully conducted metabolic flux studies by Goedeke et al. comparing the effects of SGLT2i and exogenous ketones suggest differential effects. Thus, the mechanisms of action for SGLT2i are likely pleiotropic, and further work is needed to fully understand their beneficial effects.

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI187097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11645137PMC

Publication Analysis

Top Keywords

mechanisms action
8
ketosis search
4
search mechanism
4
mechanism underlying
4
underlying sglt2-inhibitor
4
sglt2-inhibitor benefit
4
benefit continues
4
continues despite
4
despite impressive
4
impressive clinical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!